Next Article in Journal
Weighted z-Distance-Based Clustering and Its Application to Time-Series Data
Next Article in Special Issue
Accuracy of Five Intraoral Scanners and Two Laboratory Scanners for a Complete Arch: A Comparative In Vitro Study
Previous Article in Journal
Improving Localization of Deep Inclusions in Time-Resolved Diffuse Optical Tomography
Previous Article in Special Issue
Effectiveness of Vapor Lock Effect Removal in Endo Training Blocks: Manual Dynamic Agitation versus Passive Ultrasonic Irrigation
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Antibacterial Activity and Impact of Different Antiseptics on Biofilm-Contaminated Implant Surfaces

1
Department of Oral and Maxillofacial Sciences, Sapienza University of Rome, 00161 Rome, Italy
2
Department of Public Health and Infectious Diseases, Section of Microbiology, Sapienza University of Rome, 00161 Rome, Italy
3
National Centre of Drug Research and Evaluation, Istituto Superiore di Sanità, 00161 Rome, Italy
*
Author to whom correspondence should be addressed.
Appl. Sci. 2019, 9(24), 5467; https://doi.org/10.3390/app9245467
Submission received: 25 October 2019 / Revised: 3 December 2019 / Accepted: 10 December 2019 / Published: 12 December 2019
(This article belongs to the Special Issue Applied Sciences in Dentistry)

Abstract

:
Several antiseptic agents have been proposed for the treatment of peri-implantitis as a complementary therapeutic strategy in addition to mechanical devices. The aim of this study was to compare six different antiseptics, as well as alternative formulations of the same chemical agent, with respect to their decontamination efficacy and impact on chemical properties of the implant surface. Titanium disks with a micro-rough surface, previously contaminated with Porphyromonas gingivalis and Streptococcus mutans biofilms, were treated for 2 min with different antiseptics (liquid sodium hypochlorite 5.25%, gel sodium hypochlorite 5.25%, liquid chlorhexidine 0.2%, gel chlorhexidine 1%, gel citric acid 40%, and gel orthophosphoric acid 37%) or sterile saline solution (control) and their antibacterial activity as well as their ability to remove biofilm were assessed by viable bacterial count and scanning electron microscopy, respectively. Spectroscopic analysis was also performed on non-contaminated disks after exposure to the antiseptics, in order to detect any change in the elemental composition of the titanium surface. All the antimicrobial formulations examined were effective against P. gingivalis and S. mutans biofilms. SEM analysis revealed however that liquid sodium hypochlorite 5.25% was more effective in dissolving biofilm residues. Spectroscopic analysis detected traces of the antiseptics, probably due to insufficient rinsing of the titanium surfaces. In conclusion, since gel formulations of these antiseptic agents possessed a similar antibacterial activity to the liquid formulations, these may be proposed as alternative treatments given their properties to avoid overflows and increase contact time without significant side effects on the bone.

1. Introduction

Implant failure due to biological complications, such as peri-implantitis, represents a major concern in implant rehabilitation. According to a recent literature review, the prevalence of peri-implantitis is 19.83% on subject-based evaluation, making this an emerging oral health issue [1]. Despite this high frequency, standardized therapy for peri-implantitis has not been established, though several treatments have been proposed to arrest disease progression and obtain re-osseointegration [2].
According to the most widely diffused theory, the accumulation of a biofilm is the primary etiological factor of peri-implantitis [3], while different microbial species, specifically Porphyromonas gingivalis and Streptococcus mutans, contribute to its development and progression. In fact, both microorganisms are responsible for oral diseases and, in particular, P. gingivalis is recognized as most closely linked to the development of peri-implantitis while S. mutans is known to favor the development of a biofilm coating on titanium surfaces [4]. On this matter, Mombelli and Lang [5] provided at least five lines of evidence to support the bacterial etiology of peri-implantitis, findings also confirmed by the World Workshop for the Classification of Periodontal and Peri-Implant Diseases and Conditions [6]. Due to the eminently bacterial etiology of the disease, surface decontamination is considered a cardinal principle of the therapy and a prerequisite for restoring bone defects around infected implants. Implant decontamination is based on two different but synergic strategies: mechanical debridement of the implant surface followed by chemical disinfection. This combined approach reflects the need to disrupt the adherent biofilm and to dissolve residual organic contaminants, allowing for re-osseointegration of the previously infected surfaces. However, the mechanical treatments cannot achieve complete removal of the biofilm due to implant design, surface roughness, and limited access to the infected surface [7]; therefore, a wide range of antiseptic agents have been proposed as adjuvant treatment for infected implants in order to reach inaccessible areas where mechanical treatments are ineffective.
The antimicrobial activity of antiseptics is based on different mechanisms of action and can be influenced by many factors such as formulation and bacterial load [8]. From a biological perspective, the ideal antiseptic agent should have rapid action, broad-spectrum antimicrobial activity and low toxicity on host cells, essential factors when topical antiseptics are used in close contact with the host tissue. Despite the numerous antiseptics proposed for the treatment of infected implants, to date, there is no evidence of the superiority of any specific antiseptic, the choice of which is mainly based on the individual preferences of clinicians. In the clinical practice, a certain degree of toxicity can always be expected when antiseptics are used in the surgical treatment of peri-implantitis, alongside possible alterations of the physicochemical properties of implant surfaces [9]. Indeed, these alterations have been shown to affect osteoblastic differentiation of mesenchymal stem cells, osteoblast maturation, as well as the production of factors that regulate bone formation, influencing, thereby, the process of osseointegration [9,10]. As a result, it is important to evaluate the effects of antiseptic agents on titanium surface by detecting any change in the elemental composition.
Therefore, in order to reduce the significant side effects on the bone, it might be helpful to confine the antiseptic agent to the infected surface and, in this regard, gel formulation might represent a valid approach since it avoids overflows and allows an increased contact time.
To the authors’ knowledge, no study has investigated the effects of different formulations of the same chemical agent on contaminated implant surfaces. The aim of this in vitro study was to assess the antibacterial efficacy of commercially available antiseptics, including alternative formulations of the same chemical agent, on P. gingivalis and S. mutans biofilms formed on titanium disks with micro-rough surfaces. In addition, the effects of these antiseptics on the surface chemical properties were evaluated.

2. Materials and Methods

2.1. Titanium Disks

Disks of commercial pure titanium grade 4 ASTM (American Society for Testing and Materials, West Conshohocken, Pennsylvania, US) were used for the study. The disks (10 mm diameter, 1.5 mm thickness) had a moderately rough (Sa (average roughness) 1.30 µm [11]) sandblasted and acid-etched surface (Camlog Promote®, Basel, Switzerland). Each disk was sterilized by dry heat sterilization before the experimental procedure.

2.2. Antiseptic Products

Sodium hypochlorite (NaOCl), chlorhexidine (CHX), citric acid (CA), and orthophosphoric acid (OPA) were used as test antiseptics. Specifically, the following specific commercial formulations were investigated:
(1)
NaOCl 5.25%, liquid (Chloraxid, Cerkamed);
(2)
NaOCl 5.25%, gel (Chloraxid, Cerkamed);
(3)
CHX 0.2%, liquid (Curasept);
(4)
CHX 1%, gel (Curasept);
(5)
CA 40%, liquid (Cerkamed);
(6)
OPA 37%, gel (Axia etch).

2.3. Bacterial Strains and Growth Conditions

Standard reference strains of Streptococcus mutans ATCC 25,175 and Porphyromonas gingivalis ATCC 33,277 (Thermo Fisher Scientific Inc., Waltham, MA, USA) were used in this study. S. mutans was grown on Brain Heart Infusion agar (BHI, Oxoid, Basingstoke, UK ) under aerobic conditions at 37 °C for 48 h, whereas P. gingivalis was grown on Tryptone Soy Agar (TSA, Oxoid, Basingstoke, UK), supplemented with 10% horse serum (Sigma-Aldrich, St. Louis, USA), hemin (5 mg/mL; AppliChem, Darmstadt, Germany), and vitamin K1 (10 mg/mL; Sigma) (complete TSA), and anaerobically incubated at 37 °C for 4–5 days, using the Anaerocult A system (Merck, Darmstadt, Germany). All strains were stored at −80 °C in BHI broth containing 20% glycerol.

2.4. Preparation of Saliva

Unstimulated saliva samples were obtained, with informed consent, from one nonsmoker healthy volunteer, who did not have active carious lesions, periodontal disease or any other oral disease.
The saliva samples were collected for one hour a day, at least 1.5 h after eating, drinking, or teeth brushing, for seven days. Subsequently, the saliva samples were pooled and clarified by centrifugation (30 min; 4 °C; 15,000× g). The supernatant obtained was pasteurized (30 min; 60 °C), re-centrifuged (30 min; 4 °C; 15,000× g), and, finally, stored at −20 °C.
The lack of any bacterial growth was evaluated by plating 100 µL of saliva on blood agar plates incubated under aerobic and anaerobic conditions at 37 °C for 48–72 h.

2.5. Biofilm Formation

Overnight cultures of S. mutans and P. gingivalis were used for the biofilm formation. Briefly, S. mutans cultures were grown in BHI at 37 °C, and then diluted in fresh BHI up to an optical density of 0.7 at 610 nm (∼1 × 109 colony-forming unit per milliliter (CFU/mL)). P. gingivalis cultures were grown in BHI broth supplemented with hemin (5 mg/mL; AppliChem) and vitamin K1 (1 mg/mL; Sigma) at 37 °C. The bacterial concentration was then adjusted by measuring optical density at 620 nm to 0.08–0.1 nm (∼1.2 × 108 CFU/mL).
Sterilized titanium disks were placed in 24-well cell culture plates and incubated with 400 µL of human saliva at 37 °C in an orbital shaker (75 rpm). After 4 h, the saliva was removed and the disks were washed with sterile saline solution (0.9% NaCl). For S. mutans biofilm formation, each saliva-coated disk was covered with 800 µL of BHI broth supplemented with 1% sucrose and incubated at 37 °C for 30 min. Next, the disks were inoculated with 100 µL of bacterial suspension and anaerobically incubated at 37 °C for 48 h. For P. gingivalis biofilm formation, each saliva-coated disk was pre-incubated at 37 °C for 30 min, with 1.2 mL of BHI broth supplemented as described above. The disks were then inoculated with 200 µL of bacterial suspension and incubated at 37 °C under anaerobic conditions for 48 h. The biomass of bacterial biofilm was determined by crystal violet (CV) staining, as described by Yoshida [12].

2.6. Exposure of Biofilms to Antiseptic Products

The 48 h old biofilm disks were washed three times with sterile saline solution and placed in new wells. These biofilm disks were then covered with 1 mL of the antiseptic compound or with a sterile saline solution (untreated control). After two minutes of exposure, the treated disks were transferred to sterile tubes containing D/E neutralizing broth and glass beads, and vortexed vigorously for 2 min. Serial dilutions of the re-suspended biofilm solutions were performed in sterile saline solution. Following this, two aliquots (1 mL) from each dilution were plated in BHI agar for S. mutans or in complete TSA agar for P. gingivalis and incubated as described above. The viable bacterial count was expressed as colony-forming units (CFU)/mL.
Simultaneously, the disks were aseptically transferred in sterile Petri plates and covered with BHI agar for S. mutans or complete TSA for P. gingivalis and incubated as described above. The viable bacterial count was expressed as “CFU/disk”.
The neutralizing activity of D/E was verified by the quantitative suspension test according to DIN EN 1040.

2.7. Scanning Electron Microscopy Analysis (SEM)

Biofilm-covered disks treated with antiseptic agents or sterile saline solution were fixed with 2% glutaraldehyde in 0.1 M cacodylate buffer (pH 7.4) at room temperature for 2 h, post-fixed with 1% OsO4 in the same buffer for 1 h, dehydrated through a graded ethanol series, critical point dried with CO2 (CPD 030 Balzers device, Bal-Tec, Balzers, Liechtenstein), and gold coated by sputtering (SCD040 Balzers device, Bal-Tec). Specimens were analyzed using a field emission gun scanning electron microscope (FEG-SEM) (Inspect FTM; FEI Company, Hillsboro, OR, USA).

2.8. Spectroscopic Analysis

Titanium surface chemical analysis was carried out using X-ray photoelectron spectroscopy (XPS) (Escalam MKII, Vacuum Generators). Three diskss for each treatment plus one untreated control were analyzed. Before treatment, each sample previously sterilized by autoclaving was given an ultrasonic bath with acetone and with 95% ethyl alcohol, each for 2 min, and air dried. Each disk was then immersed for 2 min in the antiseptic solution, subsequently washed first with 10 mL of sterile saline solution and then with 10 mL of sterile bidistilled water.

2.9. Statistical Analysis

Data were expressed as means ± standard deviation (SD) of at least three replicates from two independent experiments. Antibacterial activity was expressed by log10 reduction factor (RF): RF = log10nc − log10nu, where nc = number of viable cells (CFU) in the re-suspended biofilm solution of untreated control, and nu = number of viable cells (CFU) in the re-suspended biofilm solution after contact with antiseptic treatments.
Statistical analysis was performed using one-way ANOVA with a Tukey′s multiple comparisons test. p values were considered statistically significant when p < 0.05. Statistical analyses and graphs were produced in GraphPad Prism software v. 7.05. The log10 reduction factor (RF) data were calculated in Excel (MS Excel, 2013), as described above.

3. Results

3.1. Antibacterial Activity

The antibacterial activity against P. gingivalis and S. mutans biofilms formed on human saliva-coated titanium surfaces was investigated via the total bacteria count and expressed as reduction factor (RF). As shown in Table 1, all of the antiseptic agents showed a similar antibacterial activity against P. gingivalis and S. mutans biofilm as compared to control (p < 0.01). Specifically, NaOCl 5.25% and OPA appeared to be more effective than the other antiseptics agents, although the differences were not statistically significant.

3.2. SEM Analysis

The photomicrographs of P. gingivalis and S. mutans biofilms following the antiseptic treatments are shown in Figure 1. The control disks revealed a different biofilm growth pattern for S. mutans and P. gingivalis: the first forming a multilayer structure, the second appearing as small clusters or isolated coccobacilli of 0.5–1 μm diameter. Microscopic analysis showed a substantial reduction of biofilm mass on all of the samples. Specifically, no bacterial aggregates were found on the contaminated titanium surfaces treated by liquid 5.25% NaOCl. Conversely, the contaminated titanium surfaces treated with the other antiseptics showed some remnants of bacterial cells.

3.3. Spectroscopic Analysis

Carbon and oxygen were the predominant elements on the surface of all samples. These elements result either from test substances or environmental contamination. Titanium was revealed in small proportions as a consequence of environmental contamination by organic compounds or alteration of the surface due to exposure to test agents. The curves of the normalized spectra of Ti2p (Figure 2) are very similar to each other, indicating that the Ti–O bond in TiO2 (459.3 eV) is dominant in all samples. Other potential bonds formed by titanium cannot be distinguishable on the Ti2p spectra due to their small chemical shifts with respect to the Ti–O bond. Interestingly, titanium could not be detected in the sample treated with 37% OPA acid.
Spectra relative to the peak O1s (Figure 3) show very different characteristics among the samples. Each spectrum can be interpreted as a composition of peaks at the characteristic energies of the different bonds in different proportions from one sample to another. All samples show the peak corresponding to the Ti–O bond, together with the peaks of the C = O, C–O and OH bonds. Sample F, the only one that contained phosphorus, showed a predominance of the peak corresponding to the P–O bond.
C1s spectra (Figure 4) also differed among the samples. These spectra are the result of the composition of numerous peaks corresponding to the energies of the different bonds indicated in the figure, and present in different proportions. In particular, O = C–O, C–C, O, C–OH, and C–NH bonds were observed. The Ti–C bond was not detected.
Sodium was detectable in all samples, in small and always different proportions. Even nitrogen was always visible, but at the limit of detectability. The chlorine signal was absent in the CC and F samples, while in the other samples it was not quantifiable. Phosphorus was present only in sample F.

4. Discussion

In this study, the decontamination efficacy of six commercially available antiseptic agents against P. gingivalis and S. mutans biofilms on micro-rough titanium disks, and their effects on surface chemical composition, were assessed.
To reach our goal, we developed an in vitro biofilm model resembling the in vivo physiological microenvironment as closely as possible. As described above, P. gingivalis is one of the pathogens most often associated with peri-implantitis [13], and S. mutans is able to form a greater quantity of biofilm, favoring the colonization of P. gingivalis [14]. The titanium disks were exposed to human saliva in order to reproduce the physiological protein layer known to mediate bacterial adhesion on the implant surface in vivo. Disks with moderate surface roughness (Sa:1.30 µm) were used as 95% of the surfaces in currently commercialized implant systems are composed of titanium with a moderately rough topography [15], and the greater affinity of bacteria and peri-implantitis progression for this type of surfaces is well-known [16,17].
In this study, marked antibacterial activity against P. gingivalis and S. mutans biofilms following 2 min of exposure was demonstrated for 5.25% NaOCl liquid and gel, followed by 37% OPA gel, 40% CA liquid, 1% CHX gel, and 0.2% CHX liquid formulations. However no significant difference in their antibacterial activity was observed despite 5.25% NaOCl appearing to be the most effective in removing the biofilms. Indeed, as evidenced by SEM analysis, disks treated with liquid 5.25% NaOCl showed a reduced biofilm matrix and no residual bacterial cells.
Overall, our findings are in agreement with other studies that have not found significant differences in the decontaminating efficacy between the most commonly used antiseptics [18,19,20].
The antimicrobial properties of NaOCl have been thoroughly investigated with respect to its endodontic application as an irrigant [21,22], while less is known about its effect on infected implants [23]. The germicidal action of NaOCl depends on its dissociation into sodium hydroxide and hypochlorous acid, which has a high oxidizing power and can easily penetrate inside bacterial cells leading to irreversible enzyme inhibition, lysis of the cytoplasmic membrane, degradation of phospholipids, and alterations of cellular metabolism [24]. However, NaOCl is highly cytotoxic for host cells, including osteoblasts and fibroblasts. In fact, following the exposure of canine bone samples to 5.25% NaOCl liquid for 30 min, Kerbl et al. [25] observed macroscopic demineralization and degradation of the organic matrix. Another study demonstrated that the toxicity of NaOCl liquid on human bone marrow mesenchymal stem cells was proportional to its concentration and the exposure time [26]. Thus, the 5.25% NaOCl liquid formulation cannot be recommended for surgical treatment of peri-implantitis. The NaOCl gel formulation, which is equally effective against P. gingivalis and S. mutans biofilms as evidenced in our study, may however represent a potential alternative treatment. Similar results were also observed for the 37% OPA and 1% CHX gel formulations, further supporting the possible use of antiseptic gels for the treatment of infected implant surfaces, since gel formulations may limit the accidental contact of the antiseptic agent to the surrounding tissues. CHX has however also been shown to possess cytotoxic effect against host tissues [27,28,29,30], whereas OPA’s cytotoxic properties have been highlighted by a single study and, hence, warrants further investigation [31].
In this regard, a more interesting finding of our study shows that 40% CA had similar antibacterial activity to the 5.25% NaOCl as well as the 37% OPA formulations. This evidence is of especial clinical importance as CA has been demonstrated to be well tolerated by host cells. One study also observed that 50% CA favored the adhesion and proliferation of pre-osteoblastic cells on bone as a result of the demineralization and consequent formation of a micro-rough substrate similar to that produced by osteoclasts [32].
In addition to the antibacterial activity toward biofilm contaminated implants, our results also evidenced that NaOCl, OPA, CA, and CHX did not produce significant alterations in surface chemical properties, avoiding potential detrimental effects on surrounding tissues [20]. Indeed, NaOCl, CA and CHX have not altered the chemical structure of the titanium oxide surface layer as evidenced by spectroscopic analysis. However, titanium could not be detected on the sample treated with OPA, suggesting the formation of a layer of corrosion products consisting of titanium oxide phosphate [33], and this deserves further investigation. Moreover, multiple elements such as carbon, chlorine, sodium, and phosphorus were detected on treated titanium disks, suggesting adsorption and/or residual traces of decontaminating substances on the surface. Titanium disk surfaces can be altered by either a direct action of the substance on the surface or, more likely, by the adsorption and permanence of the chemical agent. Our results point to a potential chemical contamination of the surface, which may be due to inadequate washing of decontaminated titanium disks. Prolonged rinsing of the treated surfaces might then be required in clinical practice. Also, we cannot exclude that the chemical surface contamination of treated titanium disks might compromise their biocompatibility with host tissues. In fact, Kotsakis et al. showed the presence of elemental contaminants of NaOCl and CHX on decontaminated surfaces that lead to a cytotoxic effect of the host tissues, potentially compromising the biocompatibility of treated surfaces [20]. In addition to chemical surface contamination by antiseptic agents, chemical alterations of the titanium oxide layer can be also caused by the peri-implantitis environment, the inflammatory process and acids originated by the bacterial metabolism [34,35,36,37,38]. It is not clear, however, whether local corrosion phenomena affect re-osseointegration. On this, a protocol aimed at restoring the atomic composition of the titanium oxide surface layer, based on the combined use of hydrogen peroxide and CO2 laser, was also investigated, although with controversial results [39,40].
The main limitation of this study is that it utilizes an in vitro system that warrants caution in translating results to clinical practice as host defense mechanisms and local tissue detoxification, and the influence of blood flow should also be considered. In our study we set up a biofilm model grown on a titanium surface better to simulate the oral microenvironment, which uses human saliva-coated surfaces, the most common periodontal pathogens, anaerobic conditions during biofilm formation and routine exposure time.
In the future, ex vivo studies with multispecies biofilm will be of great help to identify the most promising antiseptic agent, in terms of antibacterial, anti-biofilm, and biocompatibility properties, for the standardization of peri-implantitis treatment.

5. Conclusions

The present in vitro study aimed to assess the decontamination efficacy and impact on surface chemical composition of six commercially available antiseptic agents on titanium disks with micro-rough surfaces contaminated with mono-species biofilms.
Overall our results showed that NaOCl, OPA, CHX, and CA possess antibacterial activity against P. gingivalis and S. mutans biofilms. Importantly, the promising antibacterial activity of gel formulations (NaOCl, OPA and CHX) suggests these as alternative approaches in clinical practice during the surgical treatment of peri-implantitis. Gel formulations, by prolonging the contact time, could be more effective toward oral pathogens and, simultaneously, could limit the accidental contact with peri-implant tissues; investigating these aspects in more detail might be of interest in future research.
More importantly, the antiseptics examined did not modify the chemical composition of the titanium disks, though the effects of OPA merits further study. Some contaminant residues were detected, however, suggesting the necessity of prolonged washing with saline solution following implant surface exposure to antiseptics. Within the limits of this study, our results indicate that these antiseptic agents may be beneficial as a complementary treatment to mechanical debridement for the elimination of biofilm on rough implant surfaces in the treatment of peri-implantitis.

Author Contributions

Conceptualization, M.L., R.S., and A.D.B.; methodology, M.L.; investigation, M.L., S.F., G.B., and M.D.P.; data curation, S.F. and G.B.; writing—original draft preparation, M.L. and S.F.; writing—review and editing, I.V. and M.D.P.; supervision, A.D.B., A.M., and L.L.; funding acquisition, M.L. and A.D.B.

Funding

This research was funded by Oral Reconstruction Foundation (Basel, Switzerland) grant number ORF-11701.

Acknowledgments

The titanium samples used in the study were kindly provided by Camlog Biotechnologies AG. The authors wish to acknowledge Emanuele Serra, Theodoros Dikonimos, and Francesca Menchini (ENEA Research Center “Casaccia”) for the XPS analysis, and Giulia Tranquilli for support in the laboratory microbiological analysis.

Conflicts of Interest

The authors declare no conflicts of interest.

References

  1. Lee, C.T.; Huang, Y.W.; Zhu, L.; Weltman, R. Prevalences of peri-implantitis and peri-implant mucositis: Systematic review and meta-analysis. J. Dent. 2017, 62, 1–12. [Google Scholar] [CrossRef] [PubMed]
  2. Lollobrigida, M.; Fortunato, L.; Lamazza, L.; Serafini, G.; De Biase, A. Re-osseointegration after the surgical treatment of induced peri-implantitis. Systematic review on current evidence and translation from the animal to the human model. Minerva Stomatol. 2019. ahead of print. [Google Scholar]
  3. Lang, N.P.; Berglundh, T. Working Group 4 of Seventh European Workshop on Periodontology. Periimplant diseases: Where are we now?—Consensus of the Seventh European Workshop on Periodontology. J. Clin. Periodontol. 2011, 38 (Suppl. S11), 178–181. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  4. Ji, M.K.; Park, S.W.; Lee, K.; Kang, I.C.; Yun, K.D.; Kim, H.S. Lim, H.P. Evaluation of antibacterial activity and osteoblast-like cell viability of TiN, ZrN and (Ti1-xZrx)N coating on titanium. J. Adv. Prosthodont. 2015, 7, 166–171. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  5. Mombelli, A.; Lang, N.P. The diagnosis and treatment of peri-implantitis. Periodontology 2000 1998, 17, 63–76. [Google Scholar] [CrossRef] [PubMed]
  6. Berglundh, T.; Armitage, G.; Araujo, M.G.; Avila-Ortiz, G.; Blanco, J.; Camargo, P.M.; Chen, S.; Cochran, D.; Derks, J.; Figuero, E.; et al. Peri-implant diseases and conditions: Consensus report of workgroup 4 of the 2017 World Workshop on the Classification of Periodontal and Peri-Implant Diseases and Conditions. J. Clin. Periodontol. 2018, 45 (Suppl. S20), S286–S291. [Google Scholar] [CrossRef] [Green Version]
  7. Steiger-Ronay, V.; Merlini, A.; Wiedemeier, D.B.; Schmidlin, P.R.; Attin, T.; Sahrmann, P. Location of unaccessible implant surface areas during debridement in simulated peri-implantitis therapy. BMC Oral Health 2017, 17, 137. [Google Scholar] [CrossRef] [Green Version]
  8. McDonnell, G.; Russell, A.D. Antiseptics and disinfectants: Activity, action, and resistance. Clin. Microbiol. Rev. 1999, 12, 147–179. [Google Scholar] [CrossRef] [Green Version]
  9. Wheelis, S.E.; Gindri, I.M.; Valderrama, P.; Wilson, T.G., Jr.; Huang, J.; Rodrigues, D.C. Effects of decontamination solutions on the surface of titanium: Investigation of surface morphology, composition, and roughness. Clin. Oral Implant. Res. 2016, 27, 329–340. [Google Scholar] [CrossRef]
  10. Sedlaczek, J.; Lohmann, C.H.; Lotz, E.M.; Hyzy, S.L.; Boyan, B.D.; Schwartz, Z. Effects of low-frequency ultrasound treatment of titanium surface roughness on osteoblast phenotype and maturation. Clin. Oral Implant. Res. 2017, 28, e151–e158. [Google Scholar] [CrossRef]
  11. Dohan Ehrenfest, D.M.; Vazquez, L.; Park, Y.J.; Sammartino, G.; Bernard, J.P. Identification card and codification of the chemical and morphological characteristics of 14 dental implant surfaces. J. Oral Implantol. 2011, 37, 525–542. [Google Scholar] [CrossRef] [PubMed]
  12. Yoshida, A.; Ansai, T.; Takehara, T.; Kuramitsu, K.H. LuxS-Based Signaling Affects Streptococcus mutans Biofilm Formation. Appl. Environ. Microbiol. 2005, 71, 2372–2380. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  13. Persson, G.R.; Renvert, S. Cluster of bacteria associated with peri-implantitis. Clin. Implant Dent. Relat. Res. 2014, 16, 783–793. [Google Scholar] [CrossRef] [PubMed]
  14. Pita, P.P.C.; Rodrigues, J.A.; Ota-Tsuzuki, C.; Miato, T.F.; Zenobio, E.G.; Giro, G.; Figueiredo, L.C.; Gonçalves, C.; Gehrke, S.A.; Cassoni, A.; et al. Oral streptococci biofilm formation on different implant surface topographies. BioMed. Res. Int. 2015, 2015, 159625. [Google Scholar] [CrossRef]
  15. Bermejo, P.; Sánchez, M.C.; Llama-Palacios, A.; Figuero, E.; Herrera, D.; Sanz Alonso, M. Biofilm formation on dental implants with different surface micro-topography: An in vitro study. Clin. Oral Implant. Res. 2019, 30, 725–734. [Google Scholar] [CrossRef]
  16. Subramani, K.; Jung, R.E.; Molenberg, A.; Hammerle, C.H. Biofilm on dental implants: A review of the literature. Int. J. Oral Maxillofac. Implant. 2009, 24, 616–626. [Google Scholar]
  17. Albouy, J.P.; Abrahamsson, I.; Persson, L.G.; Berglundh, T. Spontaneous progression of peri-implantitis at different types of implants. An experimental study in dogs. I: Clinical and radiographic observations. Clin. Oral Implant. Res. 2008, 19, 997–1002. [Google Scholar] [CrossRef]
  18. Gosau, M.; Hahnel, S.; Schwarz, F.; Gerlach, T.; Reichert, T.E.; Bürgers, R. Effect of six different peri-implantitis disinfection methods on in vivo human oral biofilm. Clin. Oral Implant. Res. 2010, 21, 866–872. [Google Scholar]
  19. Bürgers, R.; Witecy, C.; Hahnel, S.; Gosau, M. The effect of various topical peri-implantitis antiseptics on Staphylococcus epidermidis, Candida albicans, and Streptococcus sanguinis. Arch. Oral Biol. 2012, 57, 940–947. [Google Scholar] [CrossRef]
  20. Kotsakis, G.A.; Lan, C.; Barbosa, J.; Lill, K.; Chen, R.; Rudney, J.; Aparicio, C. Antimicrobial agents used in the treatment of peri-implantitis alter the physicochemistry and cytocompatibility of titanium surfaces. J. Periodontol. 2016, 87, 809–819. [Google Scholar] [CrossRef]
  21. Mohammadi, Z. Sodium hypochlorite in endodontics: An update review. Int. Dent. J. 2008, 58, 329–341. [Google Scholar] [CrossRef] [PubMed]
  22. Prada, I.; Micó-Muñoz, P.; Giner-Lluesma, T.; Micó-Martínez, P.; Muwaquet-Rodríguez, S.; Albero-Monteagudo, A. Update of the therapeutic planning of irrigation and intracanal medication in root canal treatment. A literature review. J. Clin. Exp. Dent. 2019, 11, e185–e193. [Google Scholar] [CrossRef] [PubMed]
  23. Chen, C.J.; Chen, C.C.; Ding, S.J. Effectiveness of Hypochlorous Acid to Reduce the Biofilms on Titanium Alloy Surfaces in Vitro. Int. J. Mol. Sci. 2016, 17, 1161. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  24. Estrela, C.; Estrela, C.R.; Barbin, E.L.; Spanó, J.C.; Marchesan, M.A.; Pécora, J.D. Mechanism of action of sodium hypochlorite. Braz. Dent. J. 2002, 13, 113–117. [Google Scholar] [CrossRef]
  25. Kerbl, F.M.; DeVilliers, P.; Litaker, M.; Eleazer, P.D. Physical effects of sodium hypochlorite on bone: An ex vivo study. J. Endod. 2012, 38, 357–359. [Google Scholar] [CrossRef]
  26. Alkahtani, A.; Alkahtany, S.M.; Anil, S. An in vitro evaluation of the cytotoxicity of varying concentrations of sodium hypochlorite on human mesenchymal stem cells. J. Contemp. Dent. Pract. 2014, 15, 473–481. [Google Scholar]
  27. Goldschmidt, P.; Cogen, R.; Taubman, S. Cytopathologic effects of chlorhexidine on human cells. J. Periodontol. 1977, 48, 212–215. [Google Scholar] [CrossRef]
  28. Mariotti, A.J.; Rumpf, D.A. Chlorhexidine-induced changes to human gingival fibroblast collagen and non-collagen protein production. J. Periodontol. 1999, 70, 1443–1448. [Google Scholar] [CrossRef]
  29. Vörös, P.; Dobrindt, O.; Perka, C.; Windisch, C.; Matziolis, G.; Röhner, E. Human osteoblast damage after antiseptic treatment. Int. Orthop. 2014, 38, 177–182. [Google Scholar] [CrossRef] [Green Version]
  30. Wyganowska-Swiatkowska, M.; Kotwicka, M.; Urbaniak, P.; Nowak, A.; Skrzypczak-Jankun, E.; Jankun, J. Clinical implications of the growth-suppressive effects of chlorhexidine at low and high concentrations on human gingival fibroblasts and changes in morphology. Int. J. Mol. Med. 2016, 37, 1594–1600. [Google Scholar] [CrossRef] [Green Version]
  31. Prado, M.; Silva, E.J.; Duque, T.M.; Zaia, A.A.; Ferraz, C.C.R.; Almeida, J.F.; Gomes, B.P. Antimicrobial and cytotoxic effects of phosphoric acid solution compared to other root canal irrigants. J. Appl. Oral Sci. 2015, 23, 158–163. [Google Scholar] [CrossRef]
  32. De Rezende, M.L.; Coesta, P.T.; de Oliveira, R.C.; Salmeron, S.; Sant’Ana, A.C.; Damante, C.A.; Greghi, S.L.; Consolaro, A. Bone demineralization with citric acid enhances adhesion and spreading of preosteoblasts. J. Periodontol. 2015, 86, 146–154. [Google Scholar] [CrossRef]
  33. Prando, D.; Brenna, A.; Diamanti, M.V.; Beretta, S.; Bolzoni, F.; Ormellese, M.; Pedeferri, M. Corrosion of Titanium: Part 1: Aggressive Environments and Main Forms of Degradation. J. Appl. Biomater. Func. 2017, 15, e291–e302. [Google Scholar] [CrossRef]
  34. Lausmaa, J. Surface spectroscopic characterization of titanium implant materials. J. Electron Spectrosc. 1996, 81, 343–361. [Google Scholar] [CrossRef]
  35. Ungvári, K.; Pelsöczi, I.K.; Kormos, B.; Oszkó, A.; Rakonczay, Z.; Kemény, L.; Radnai, M.; Nagy, K.; Fazekas, A.; Turzó, K. Effects on titanium implant surfaces of chemical agents used for the treatment of peri-implantitis. J. Biomed. Mater. Res. B Appl. Biomater. 2010, 94, 222–229. [Google Scholar] [CrossRef]
  36. Mouhyi, J.; Dohan Ehrenfest, D.M.; Albrektsson, T. The peri-implantitis: Implant surfaces, microstructure, and physicochemical aspects. Clin. Implant Dent. Relat. Res. 2012, 14, 170–183. [Google Scholar] [CrossRef]
  37. Souza, J.; Henriques, M.; Teughels, W.; Ponthiaux, P.; Celis, J.; Rocha, L. Corrosion Interactions on Titanium in Oral Environment: Literature Review. J. Bio Tribo Corros. 2015, 1, 13. [Google Scholar] [CrossRef] [Green Version]
  38. Sridhar, S.; Wilson, T.G., Jr.; Palmer, K.L.; Valderrama, P.; Mathew, M.T.; Prasad, S.; Jacobs, M.; Gindri, I.M.; Rodrigues, D.C. In Vitro Investigation of the Effect of Oral Bacteria in the Surface Oxidation of Dental Implants. Clin. Implant Dent. Relat. Res. 2015, 17 (Suppl. S2), e562–e575. [Google Scholar] [CrossRef]
  39. Mouhyi, J.; Sennerby, L.; Wennerberg, A.; Louette, P.; Dourov, N.; van Reck, J. Re-establishment of the atomic composition and the oxide structure of contaminated titanium surfaces by means of carbon dioxide laser and hydrogen peroxide: An in vitro study. Clin. Implant Dent. Relat. Res. 2000, 2, 190–202. [Google Scholar] [CrossRef]
  40. Persson, L.G.; Mouhyi, J.; Berglundh, T.; Sennerby, L.; Lindhe, J. Carbon dioxide laser and hydrogen peroxide conditioning in the treatment of periimplantitis: An experimental study in the dog. Clin. Implant Dent. Relat. Res. 2004, 6, 230–238. [Google Scholar] [CrossRef]
Figure 1. SEM images (magnification ×10,000) of S. mutans and P. gingivalis biofilms attached on titanium surface after exposure to antiseptics for 2 min. NaOCl, sodium hypochlorite; CHX, chlorhexidine; CA, citric acid; OPA, orthophosphoric acid; control, NaCl 0.9%.
Figure 1. SEM images (magnification ×10,000) of S. mutans and P. gingivalis biofilms attached on titanium surface after exposure to antiseptics for 2 min. NaOCl, sodium hypochlorite; CHX, chlorhexidine; CA, citric acid; OPA, orthophosphoric acid; control, NaCl 0.9%.
Applsci 09 05467 g001
Figure 2. Normalized spectra of Ti2p of non-contaminated titanium samples after immersion in 1 mL of each antiseptic product for 2 min. (CC) Control; (A) NaOCl 5.25% liquid; (B) NaOCl 5.25% gel; (C) CHX 0.2% liquid; (D) CHX 1% gel; (E) AC 40% gel.
Figure 2. Normalized spectra of Ti2p of non-contaminated titanium samples after immersion in 1 mL of each antiseptic product for 2 min. (CC) Control; (A) NaOCl 5.25% liquid; (B) NaOCl 5.25% gel; (C) CHX 0.2% liquid; (D) CHX 1% gel; (E) AC 40% gel.
Applsci 09 05467 g002
Figure 3. Normalized spectra of O1s of non-contaminated titanium samples after immersion in 1 mL of each antiseptic product for 2 min. (CC) Control; (A) NaOCl 5.25% liquid; (B) NaOCl 5.25% gel; (C) CHX 0.2% liquid; (D) CHX 1% gel; (E) AC 40% gel; (F) OPA 37% gel.
Figure 3. Normalized spectra of O1s of non-contaminated titanium samples after immersion in 1 mL of each antiseptic product for 2 min. (CC) Control; (A) NaOCl 5.25% liquid; (B) NaOCl 5.25% gel; (C) CHX 0.2% liquid; (D) CHX 1% gel; (E) AC 40% gel; (F) OPA 37% gel.
Applsci 09 05467 g003
Figure 4. Normalized spectra of C1s of non-contaminated titanium samples after immersion in 1 mL of each antiseptic product for 2 min. (CC) Control; (A) NaOCl 5.25% liquid; (B) NaOCl 5.25% gel; (C) CHX 0.2% liquid; (D) CHX 1% gel; (E) AC 40% gel; (F) OPA 37% gel.
Figure 4. Normalized spectra of C1s of non-contaminated titanium samples after immersion in 1 mL of each antiseptic product for 2 min. (CC) Control; (A) NaOCl 5.25% liquid; (B) NaOCl 5.25% gel; (C) CHX 0.2% liquid; (D) CHX 1% gel; (E) AC 40% gel; (F) OPA 37% gel.
Applsci 09 05467 g004
Table 1. Antibacterial activity of the antiseptics against P. gingivalis and S. mutans after 2 min of exposure.
Table 1. Antibacterial activity of the antiseptics against P. gingivalis and S. mutans after 2 min of exposure.
AntisepticsP. Gingivalis
RF ± SD
S. Mutans
RF ± SD
NaOCl 5.25% liquid6.3 ± 0.3 #7.2 ± 0.6 *
NaOCl 5.25% gel6.5 ± 1.0 #4.3 ± 1.7 *
CHX 0.2% liquid0.9 ± 0.02 #0.8 ± 0.03 *
CHX 1% gel6.5 ± 1.0 #0.9 ± 0.1 *
CA 40% liquid5.3 ± 0.1 #4.1 ± 0.5 *
OPA 37% gel6.2 ± 0.2 #7.1 ± 0.5 *
NaOCl, sodium hypochlorite; CHX, chlorhexidine; CA, citric acid; OPA, orthophosphoric acid; #, p < 0.0001 and *, p < 0.01 vs. control (NaCl 0.9%).

Share and Cite

MDPI and ACS Style

Lollobrigida, M.; Filardo, S.; Sessa, R.; Di Pietro, M.; Bozzuto, G.; Molinari, A.; Lamazza, L.; Vozza, I.; De Biase, A. Antibacterial Activity and Impact of Different Antiseptics on Biofilm-Contaminated Implant Surfaces. Appl. Sci. 2019, 9, 5467. https://doi.org/10.3390/app9245467

AMA Style

Lollobrigida M, Filardo S, Sessa R, Di Pietro M, Bozzuto G, Molinari A, Lamazza L, Vozza I, De Biase A. Antibacterial Activity and Impact of Different Antiseptics on Biofilm-Contaminated Implant Surfaces. Applied Sciences. 2019; 9(24):5467. https://doi.org/10.3390/app9245467

Chicago/Turabian Style

Lollobrigida, Marco, Simone Filardo, Rosa Sessa, Marisa Di Pietro, Giuseppina Bozzuto, Agnese Molinari, Luca Lamazza, Iole Vozza, and Alberto De Biase. 2019. "Antibacterial Activity and Impact of Different Antiseptics on Biofilm-Contaminated Implant Surfaces" Applied Sciences 9, no. 24: 5467. https://doi.org/10.3390/app9245467

APA Style

Lollobrigida, M., Filardo, S., Sessa, R., Di Pietro, M., Bozzuto, G., Molinari, A., Lamazza, L., Vozza, I., & De Biase, A. (2019). Antibacterial Activity and Impact of Different Antiseptics on Biofilm-Contaminated Implant Surfaces. Applied Sciences, 9(24), 5467. https://doi.org/10.3390/app9245467

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop